Entero Therapeutics, Inc. logo

Entero Therapeutics, Inc.

ENTO • NASDAQ

Entero Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jason David Sawyer, with a market cap of $10.1M.

CEOJason David Sawyer
Market Cap$10.1M
Biotechnology
Healthcare
Employees9.0
Websiteenterothera.com
Country
United States of America

Next Earnings

No upcoming earnings scheduled for Entero Therapeutics, Inc.

No earnings announcement scheduled

Earnings History

Past 5 earnings reports for Entero Therapeutics, Inc.

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Nov 19, 2025Q3 2025
-$0.64
—
-
—SEC10-Q
Aug 14, 2025Q2 2025
-$0.21
—
-
—SEC10-Q
May 15, 2025Q1 2025
-$0.28
—
-
—SEC10-Q
Nov 13, 2024Q3 2024
-$0.59Est: -$0.32
-84.4%
-
—SEC10-Q
Oct 21, 2024Q2 2024
-$3.86Est: -$0.32
-1106.3%
-
—SEC10-Q
View all filings on SEC EDGAR

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.